Insider · CIK 0001863024
Percy H. Carter
Files at BPMC (Blueprint Medicines Corp). First filing Mar 7, 2025, latest Jul 8, 2025.
In brief
Percy H. Carter files SEC Form 4 as officer at BPMC (Blueprint Medicines Corp). Since Mar 7, 2025, Percy H. Carter has reported 0 open-market buys worth $0 and 3 open-market sells worth $788k, the latest filed on Jul 8, 2025.
A track record needs three past buys with six months of prices behind them; Percy H. Carter has 0, so none is measured yet.
The newest scored trade: sold $135k of BPMC on Jul 3, 2025, filed Jul 8, 2025, scored 34 (weak).
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 34Weak | Blueprint Medicines Corp | $135k 1,051 shares | -2% | - | |
| 38Weak | Blueprint Medicines Corp | $340k 2,659 shares | -5% | - | |
| 44Moderate | Blueprint Medicines Corp | $313k 3,530 shares | -6% | - |
Transactions
Every row this insider has filed, 14 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 17, 2025 | BPMC Blueprint Medicines Corp | AGrant or award Common Stock | +21,353 | - | - | 74,508 | Jul 21, 2025 |
| Jul 17, 2025 | BPMC Blueprint Medicines Corp | DDisposition to issuer Common Stock | -56,614 | - | - | 17,894 | Jul 21, 2025 |
| Jul 17, 2025 | BPMC Blueprint Medicines Corp | UTender of shares Common Stock | -17,894 | - | - | 0 | Jul 21, 2025 |
| Jul 17, 2025 | BPMC Blueprint Medicines Corp | DDisposition to issuer Stock Option (Right to Buy)derivative | -39,200 | - | - | 0 | Jul 21, 2025 |
| Jul 17, 2025 | BPMC Blueprint Medicines Corp | DDisposition to issuer Stock Option (Right to Buy)derivative | -17,500 | - | - | 0 | Jul 21, 2025 |
| Jul 17, 2025 | BPMC Blueprint Medicines Corp | DDisposition to issuer Stock Option (Right to Buy)derivative | -25,000 | - | - | 0 | Jul 21, 2025 |
| Jul 17, 2025 | BPMC Blueprint Medicines Corp | DDisposition to issuer Stock Option (Right to Buy)derivative | -25,000 | - | - | 0 | Jul 21, 2025 |
| Jul 17, 2025 | BPMC Blueprint Medicines Corp | DDisposition to issuer Stock Option (Right to Buy)derivative | -22,000 | - | - | 0 | Jul 21, 2025 |
| Jul 3, 2025 | BPMC Blueprint Medicines Corp | SOpen-market sale Common Stock | -1,051 | $128.25 | $135k | 53,155 | Jul 8, 2025 |
| Jun 3, 2025 | BPMC Blueprint Medicines Corp | SOpen-market sale Common Stock | -241 | $127.88 | $31k | 56,624 | Jun 5, 2025 |
| Jun 3, 2025 | BPMC Blueprint Medicines Corp | SOpen-market sale Common Stock | -2,418 | $127.88 | $309k | 54,206 | Jun 5, 2025 |
| Mar 5, 2025 | BPMC Blueprint Medicines Corp | SOpen-market sale Common Stock | -3,530 | $88.80 | $313k | 56,865 | Mar 7, 2025 |
| Mar 1, 2025 | BPMC Blueprint Medicines Corp | AGrant or award Common Stock | +11,000 | $0.00 | $0 | 60,395 | Mar 4, 2025 |
| Mar 1, 2025 | BPMC Blueprint Medicines Corp | AGrant or award Stock Option (Right to Buy)derivative | +22,000 | $0.00 | $0 | 22,000 | Mar 4, 2025 |
Questions about Percy H. Carter
Answered from the filings on this page, as of the latest one.
Is Percy H. Carter buying or selling?
Not in the last 12 months. Percy H. Carter's latest open-market trade on SEC Form 4 was sold $135k of BPMC on Jul 3, 2025.
How did Percy H. Carter's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Percy H. Carter has 0.
Where does Percy H. Carter file Form 4?
Percy H. Carter has filed Form 4 at BPMC (Blueprint Medicines Corp) as Chief Scientific Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.